Atlas Trials

Effects of 2 Weeks Treatment With Dapagliflozin in Subjects With an Impaired Glucose Homeostasis on Nocturnal Substrate Oxidation

Clinical trial NCT03721874 · COMPLETED

Trial details

NCT number
NCT03721874
Sponsor
Maastricht University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Prediabetic StateSubstrate Oxidation
Start date
2019-04-30
Primary completion
2021-06-29
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.